Literature DB >> 26626478

Soy Protein Alleviates Hypertension and Fish Oil Improves Diastolic Heart Function in the Han:SPRD-Cy Rat Model of Cystic Kidney Disease.

Naser H M Ibrahim1,2,3, Sijo J Thandapilly1,2,3,4,5, Yong Jia1, Thomas Netticadan6,7,8, Harold Aukema9,10,11.   

Abstract

Abnormalities in cardiac structure and function are very common among people with chronic kidney disease, in whom cardiovascular disease is the major cause of death. Dietary soy protein and fish oil reduce kidney disease progression in the Han:SPRD-Cy model of cystic renal disease. However, the effects of these dietary interventions in preventing alterations in cardiac structure and function due to kidney disease (reno-cardiac syndrome) in a cystic kidney disease model are not known. Therefore, weanling Han:SPRD-Cy diseased (Cy/+) and normal (+/+) rats were given diets containing either casein or soy protein, and either soy or fish oil in a three-way design for 8 weeks. Diseased rats had larger hearts, augmented left ventricular mass, and higher systolic and mean arterial blood pressure compared to the normal rats. Assessment of cardiac function using two-dimensional guided M-mode and pulse-wave Doppler echocardiography revealed that isovolumic relaxation time was prolonged in the diseased compared to normal rats, reflecting a diastolic heart dysfunction, and fish oil prevented this elevation. Soy protein resulted in a small improvement in systolic and mean arterial pressure but did not improve diastolic heart function, while fish oil prevented diastolic heart dysfunction in this model of cystic kidney disease.

Entities:  

Keywords:  Blood pressure; Cardiovascular disease; Cystic kidney disease; Echocardiography; Fish oil; Isovolumic relaxation time; Reno-cardiac syndrome; Soy protein

Mesh:

Substances:

Year:  2015        PMID: 26626478     DOI: 10.1007/s11745-015-4095-8

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  55 in total

1.  Dietary fish oil alters cardiomyocyte Ca2+ dynamics and antioxidant status.

Authors:  Anisa Jahangiri; Wayne R Leifert; Karen L Kind; Edward J McMurchie
Journal:  Free Radic Biol Med       Date:  2006-01-18       Impact factor: 7.376

2.  Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats.

Authors:  Peter Wojciechowski; Danijel Juric; Xavier Lieben Louis; Sijo Joseph Thandapilly; Liping Yu; Carla Taylor; Thomas Netticadan
Journal:  J Nutr       Date:  2010-03-24       Impact factor: 4.798

3.  Long-term intake of edible oils benefits blood pressure and myocardial structure in spontaneously hypertensive rat (SHR) and streptozotocin diabetic SHR.

Authors:  Fernanda Jurema Medeiros; Cheila Gonçalves Mothé; Márcia Barbosa Aguila; Carlos Alberto Mandarim-de-Lacerda
Journal:  Prostaglandins Other Lipid Mediat       Date:  2005-09-30       Impact factor: 3.072

4.  The impact of pressure overload on coronary vascular changes following myocardial infarction in rats.

Authors:  Jiqiu Chen; Artiom Petrov; Elisa Yaniz-Galende; Lifan Liang; Hans J de Haas; Jagat Narula; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-28       Impact factor: 4.733

5.  Soy protein modification of rat polycystic kidney disease.

Authors:  M R Ogborn; N Bankovic-Calic; C Shoesmith; R Buist; J Peeling
Journal:  Am J Physiol       Date:  1998-03

6.  Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease.

Authors:  Claudia Yu-Chen Peng; Deepa Sankaran; Malcolm R Ogborn; Harold M Aukema
Journal:  Exp Biol Med (Maywood)       Date:  2009-05-08

7.  Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease.

Authors:  A Bardají; A M Vea; C Gutierrez; C Ridao; C Richart; J A Oliver
Journal:  Am J Kidney Dis       Date:  1998-12       Impact factor: 8.860

8.  EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells.

Authors:  Gerard Elberg; Dorit Elberg; Teresa V Lewis; Suresh Guruswamy; Lijuan Chen; Charlotte J Logan; Michael D Chan; Martin A Turman
Journal:  Am J Physiol Renal Physiol       Date:  2007-08-29

9.  Clinical pattern of adult polycystic kidney disease in a northeastern region of Italy.

Authors:  V Corradi; F Gastaldon; G M Virzì; M de Cal; S Soni; C Chionh; D N Cruz; M Clementi; C Ronco
Journal:  Clin Nephrol       Date:  2009-10       Impact factor: 0.975

10.  Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.

Authors:  Edwin M Spithoven; Anneke Kramer; Esther Meijer; Bjarne Orskov; Christoph Wanner; Fergus Caskey; Frederic Collart; Patrik Finne; Damian G Fogarty; Jaap W Groothoff; Andries Hoitsma; Marie-Béatrice Nogier; Maurizio Postorino; Pietro Ravani; Oscar Zurriaga; Kitty J Jager; Ron T Gansevoort
Journal:  Kidney Int       Date:  2014-05-14       Impact factor: 10.612

View more
  2 in total

1.  Genistein protects against ox-LDL-induced senescence through enhancing SIRT1/LKB1/AMPK-mediated autophagy flux in HUVECs.

Authors:  Huaping Zhang; Xiaorong Yang; Xuefen Pang; Zhenxiang Zhao; Haixia Yu; Hui Zhou
Journal:  Mol Cell Biochem       Date:  2018-11-16       Impact factor: 3.396

2.  Genistein alleviates H2O2-induced senescence of human umbilical vein endothelial cells via regulating the TXNIP/NLRP3 axis.

Authors:  Guihua Wu; Siming Li; Guangjin Qu; Jiajia Hua; Jing Zong; Xiaofeng Li; Fanghui Xu
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.